香港股市 已收市

Waters Corporation (WAT)

NYSE - Nasdaq 即時價格。貨幣為 USD。
加入追蹤清單
321.33+5.75 (+1.82%)
市場開市。 截至 01:43PM EDT。

Waters Corporation

34 Maple Street
Milford, MA 01757
United States
508 478 2000
https://www.waters.com

版塊Healthcare
行業Diagnostics & Research
全職員工7,900

高階主管

名稱頭銜支付行使價出生年份
Dr. Udit Batra Ph.D.President, CEO & Director1.17M1971
Mr. Amol ChaubalSenior VP & CFO635.66k1977
Ms. Jianqing Y. BennettSenior Vice President of TA Instruments Division & Waters Clinical Business Unit621.09k1970
Mr. Christos RossSenior VP of Global Operations & Interim Senior VP of the Waters Division
Caspar TudorDirector of Investor Relations
Ms. Keeley A. AlemanSenior VP, General Counsel & Corporate Secretary897.33k1977
Ms. Kristen GarveyVice President of Corporate Communications
Mr. Patrick ConwayInterim Vice President of Human Resources
Dr. Daniel Rush Ph.D.Senior Vice President of Strategy & Transformation
John LynchTreasurer
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

公司管治

截至 2024年5月1日 止,Waters Corporation 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中:9;董事會:5;股東權利:4;現金賠償:7。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。